期刊文献+

某院耐碳青霉烯类肺炎克雷伯菌检出与耐药表型分布 被引量:27

Isolation and drug resistance phenotype distribution of carbapenem-resistant Klebsiella pneumoniae in a hospital
在线阅读 下载PDF
导出
摘要 目的了解临床分离耐碳青霉烯类肺炎克雷伯菌(CRKP)耐药表型及临床分布特征,为临床合理用药和医院感染防控提供依据。方法收集2013—2015年某医院住院患者临床分离的CRKP,分析标本来源分布及病原菌药敏同源性。结果949株非重复分离的肺炎克雷伯菌中,检出CRKP 75株(7.90%)。2013—2015年CRKP的检出率分别为1.35%、7.77%、17.04%,呈逐年上升趋势,差异有统计学意义(P<0.01)。CRKP感染部位主要为呼吸道和泌尿道,主要分布于重症监护病房(ICU)、老年病科和急诊科。CRKP对阿米卡星和复方磺胺甲口恶唑的敏感率稍高,分别为57.33%、48.00%。CRKP社区获得性感染者22例,占29.33%;医院获得性感染者53例,占70.67%。75例CRKP感染患者死亡18例(24.00%)。耐药表型分析有同源性的CRKP分为5种克隆,主要在ICU、急诊病房和老年病科等科室传播流行。结论CRKP感染的比例有逐年升高的趋势,临床应加强CRKP的监测,采取强化的感染控制措施,预防和控制CRKP的播散和流行。 ObjectiveTo analyze drug resistance phenotypes and clinical distribution characteristics of clinically isolated carbapenemresistant Klebsiella pneumoniae(CRKP), and provide evidence for rational use of antimicrobial agents and control of healthcareassociated infection(HAI). MethodsCRKP isolated from inpatients in a hospital in 2013-2015 were collected, sources of specimens and homology of antimicrobial susceptibility of pathogens were analyzed. ResultsOf 949 nonrepetitive strains of Klebsiella pneumoniae, 75(7.90%) were CRKP strains. The detection rates of CRKP from 2013 to 2015 were 1.35%, 7.77%, and 17.04% respectively, which showed an upward trend year by year, difference was statistically significant(P〈0.01). The main infection sites of CRKP were respiratory tract and urinary tract, CRKP mainly distributed in intensive care unit(ICU), geriatrics and emergency departments. Susceptibility rates of CRKP to amikacin and trimethoprim / sulfamethoxazole were 57.33% and 48.00% respectively. 22 (29.33%) cases of CRKP infection were communityacquired and 53 (70.67%) were healthcareassociated infection. 18 (24.00%)cases died among 75 CRKP infected patients. According to drug resistance phenotype analysis, there were 5 clones of CRKP strains, mainly distributed in ICU, geriatrics and emergency departments.ConclusionThe proportion of CRKP infection is increasing year by year, clinical monitoring on CRKP should be strengthened, intensive infection control measures should be tarken, so as to prevent and control the spread and prevalence of CRKP.
出处 《中国感染控制杂志》 CAS 北大核心 2017年第2期130-133,137,共5页 Chinese Journal of Infection Control
基金 上海中医药大学校级医院管理研究项目(2016YG16)
关键词 肺炎克雷伯菌 耐碳青霉烯类肺炎克雷伯菌 耐药表型 耐药性 抗药性 微生物 同源性 Klebsiella pneumoniae carbapenem-resistant Klebsiella pneumoniae drug resistance phenotype drugresistance, microbial homology
  • 相关文献

参考文献4

二级参考文献42

  • 1Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria[J]. Lancet Infect Dis, 2009, 9(4): 228-236.
  • 2Lockhart S R, Abramson M A, Beekmann S E. et al. Antimicrobial resistance among Gram-negative bacilli causing infections in Intensive Care Unit patients in the United States between 1993 and 2004[J]. J Clin Microbiol, 2007, 45(10): 3352-3359.
  • 3Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium[J]. Arch Intern Med, 2005, 165(12): 1430-1435.
  • 4Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing[S]. Twenty-first Informational Supplement, 2011, M 100-S21.
  • 5Wang M, Sahm D F, Jacoby G A. et al. Emerging plasmid- mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States[J]. Antimicrob Agents Chemother, 2004, 48(4): 1295-1299.
  • 6Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 7Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 8Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.
  • 9Brink AJ. Feldman C. Grolman DC. et al. Appropriate use of the carbapenems[J]. S Afr Med J. 2004. 94 (10 Pt 2): 857-861.
  • 10Chen S. Hu F. Zhang X. et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatrnentj]]. J Clin Microbiol , 2011. 49( 11): 4022- 4023.

共引文献728

同被引文献203

引证文献27

二级引证文献184

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部